Dr. Gary Lu
Claim this profileSt. Lukes University Health Network
Studies Melanoma
Studies Cancer
4 reported clinical trials
11 drugs studied
Area of expertise
1Melanoma
Stage IV
BRAF positive
Stage III
2Cancer
Affiliated Hospitals
Clinical Trials Gary Lu is currently running
Nivolumab Safety
for Cancer
Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.
Recruiting1 award Phase 2
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
More about Gary Lu
Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Gary Lu has experience with
- Nivolumab
- PV-10
- Pembrolizumab
- Dabrafenib Mesylate
- Trametinib Dimethyl Sulfoxide
- Ipilimumab
Breakdown of trials Gary Lu has run
Cutaneous Melanoma
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gary Lu specialize in?
Gary Lu focuses on Melanoma and Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are BRAF positive.
Is Gary Lu currently recruiting for clinical trials?
Yes, Gary Lu is currently recruiting for 2 clinical trials in Bethlehem Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Gary Lu has studied deeply?
Yes, Gary Lu has studied treatments such as Nivolumab, PV-10, Pembrolizumab.
What is the best way to schedule an appointment with Gary Lu?
Apply for one of the trials that Gary Lu is conducting.
What is the office address of Gary Lu?
The office of Gary Lu is located at: St. Lukes University Health Network, Bethlehem, Pennsylvania 18015 United States. This is the address for their practice at the St. Lukes University Health Network.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.